New Post has been published on Stock Markets Daily
New Post has been published on http://www.stockmarketsdaily.com/funamental-analysis-petmed-express-inc-nasdaqpets/10485/
Small Cap Analysis: PetMed Express, Inc. (NASDAQ:PETS)
(adsbygoogle = window.adsbygoogle || []).push();
PetMed Express, Inc. (NASDAQ:PETS) is a seldom looked at small cap pet pharmacy stock, providing animal medications. We thought it would be interesting to look at the fundamentals of the stock based on analysts estimates to see if just perhaps there may be some value in this PETS. [Trend Analysis]
PetMed Express, Inc. (NASDAQ:PETS) last traded at $15.49 after moving up 0.78% for the trading day.
PETS is trading with a trailing 12 month P/E multiple of 18.22 and an estimated forward P/E multiple of 16.31. The stock has an estimated 5 year annual growth of 2.50% and a PEG multiple of 7.29.
From a value investor perspective, as mentioned PetMed Express, Inc. trades on an estimated forward P/E multiple of 16.31. The current estimated forward P/E ratio for the market as a whole is approximately 19.82. Therefore, for value investors PETS appears to be around a underpriced.
For growth investors, who are more interested in growth into the longer term for the stock, we look at the PEG multiple (P/E to growth) of PetMed Express, Inc. (NASDAQ:PETS). This PEG multiple takes into account the expected long term growth in earnings of PetMed Express, Inc. rather than merely the growth for one full earnings period ahead.
As a rule of thumb, growth investors often believe a stock with a PEG of between 0 and 1 is considered to be underpriced, between 1 and 2 to be at fair value and over 2 to be overpriced. Based on the PEG ratio of PETS being 7.29, we consider PetMed Express, Inc. to likely be overpriced.
The mean analyst 12 month target price for PetMed Express, Inc. (NASDAQ:PETS) is currently $13.00 or 16.07% below the current price.
Additionally, the stock has been as high as $16.45 and as low as $12.07 in the last 52 weeks. Analysts are estimating that PETS will report earnings per share of $0.26 next quarter.
